Share Price and Basic Stock Data
Last Updated: January 7, 2026, 8:42 pm
| PEG Ratio | 4.04 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
DMCC Speciality Chemicals Ltd operates in the chemicals sector, focusing on specialty chemicals. The company’s stock price stood at ₹248, with a market capitalization of ₹621 Cr. Over recent years, DMCC has demonstrated a robust revenue stream, reporting total sales of ₹387 Cr for FY 2023, a notable increase from ₹326 Cr in FY 2022. The trailing twelve months (TTM) sales reached ₹496 Cr, indicating a growth trajectory. Quarterly sales figures reflect some volatility, with the highest quarterly revenue recorded at ₹104.71 Cr in September 2022, followed by a decline to ₹71.91 Cr in December 2022. However, the revenue rebounded to ₹96.50 Cr in March 2023. The company’s resilience is evident as it aims to achieve ₹431 Cr in sales for FY 2025. This growth can be attributed to strategic positioning in the specialty chemicals market, which is generally characterized by higher margins compared to commodity chemicals, thus enhancing DMCC’s revenue-generating potential.
Profitability and Efficiency Metrics
DMCC reported a net profit of ₹28 Cr for FY 2023, reflecting a decline from ₹21 Cr in FY 2022, with a corresponding earnings per share (EPS) of ₹2.75. For FY 2025, the company anticipates an increase in net profit to ₹22 Cr. The operating profit margin (OPM) stood at 9% for FY 2023, improved from 12% in FY 2022 but lower than earlier years. The interest coverage ratio (ICR) was a healthy 5.56x, indicating solid earnings relative to interest expenses. However, the return on equity (ROE) was recorded at 9.97%, which is moderate compared to industry standards. The cash conversion cycle (CCC) of 37 days suggests efficient management of working capital. DMCC’s profitability metrics indicate a stable but cautious recovery with the potential for improved margins as operational efficiencies are optimized. Nevertheless, the company faces challenges in sustaining growth in profit margins, especially given the competitive landscape of the specialty chemicals sector.
Balance Sheet Strength and Financial Ratios
As of the latest reporting, DMCC holds total reserves of ₹209 Cr against borrowings of ₹40 Cr, presenting a favorable debt-to-equity ratio of 0.20x, indicating a conservative capital structure. The company’s total assets were recorded at ₹380 Cr, with fixed assets at ₹234 Cr, while current assets provide a current ratio of 1.23x, suggesting adequate liquidity to meet short-term obligations. The price-to-book value (P/BV) ratio was noted at 3.29x, reflecting a premium valuation that implies investor confidence in future growth. The company’s return on capital employed (ROCE) was recorded at 14.1%, which is favorable compared to sector norms. However, the total debt-to-equity ratio of 0.20x reveals room for leveraging growth opportunities. The combination of healthy liquidity and manageable debt levels positions DMCC well for potential expansion, although investors should monitor the company’s ability to convert its assets into profitable operations.
Shareholding Pattern and Investor Confidence
DMCC’s shareholding structure indicates a stable promoter holding of 53.84%, which has remained constant over the past several quarters. Institutional investors hold a minor stake, with foreign institutional investors (FIIs) accounting for 0.39% and domestic institutional investors (DIIs) at 1.28%. The public segment comprises 44.49%, with a total of 22,015 shareholders, reflecting a diverse ownership base. The consistent promoter holding is a positive signal to investors, indicating confidence in the company’s long-term strategy. However, the low institutional participation suggests limited external validation, which could impact overall market perception. The gradual increase in FII participation, from a mere 0.10% to 0.39% over recent periods, hints at growing interest in DMCC. This trend could enhance liquidity and attract more institutional investors, thereby improving market confidence in the company’s future prospects.
Outlook, Risks, and Final Insight
Looking ahead, DMCC Speciality Chemicals Ltd is positioned for potential growth, driven by its strategic focus on specialty chemicals and improving operational efficiencies. The company’s ability to boost profitability metrics, particularly OPM and ROE, will be critical. However, risks remain, including fluctuations in raw material prices and competitive pressures that could affect margins. Additionally, the company’s reliance on a limited number of customers could pose a risk to revenue stability. The outlook hinges on the successful execution of growth strategies and the ability to navigate market challenges. Should DMCC capitalize on emerging opportunities in the specialty chemicals market while managing risks effectively, it could achieve sustainable growth. Conversely, failure to address operational challenges may hinder its performance in a competitive landscape. Investors should remain vigilant and consider these factors when assessing the company’s future trajectory.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| HP Adhesives Ltd | 377 Cr. | 41.2 | 79.0/40.0 | 23.4 | 20.5 | 0.97 % | 13.6 % | 9.82 % | 2.00 |
| Haryana Leather Chemicals Ltd | 29.2 Cr. | 59.5 | 88.8/56.0 | 14.0 | 89.6 | 1.68 % | 8.02 % | 5.45 % | 10.0 |
| Hardcastle & Waud Mfg Co Ltd | 47.8 Cr. | 703 | 932/600 | 22.0 | 697 | 0.00 % | 6.31 % | 2.91 % | 10.0 |
| Grauer & Weil (India) Ltd | 3,529 Cr. | 77.8 | 111/68.2 | 23.4 | 22.0 | 0.64 % | 23.3 % | 17.6 % | 1.00 |
| DMCC Speciality Chemicals Ltd | 615 Cr. | 247 | 393/230 | 22.1 | 93.8 | 1.01 % | 14.1 % | 9.97 % | 10.0 |
| Industry Average | 12,996.24 Cr | 710.97 | 66.29 | 183.02 | 0.44% | 12.99% | 25.41% | 6.41 |
Quarterly Result
| Metric | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 104.71 | 71.91 | 96.50 | 85.57 | 76.52 | 80.53 | 83.95 | 85.32 | 102.70 | 118.03 | 125.19 | 127.02 | 126.02 |
| Expenses | 101.11 | 70.83 | 80.21 | 74.60 | 66.99 | 73.41 | 76.55 | 76.47 | 87.40 | 100.29 | 110.07 | 110.14 | 112.01 |
| Operating Profit | 3.60 | 1.08 | 16.29 | 10.97 | 9.53 | 7.12 | 7.40 | 8.85 | 15.30 | 17.74 | 15.12 | 16.88 | 14.01 |
| OPM % | 3.44% | 1.50% | 16.88% | 12.82% | 12.45% | 8.84% | 8.81% | 10.37% | 14.90% | 15.03% | 12.08% | 13.29% | 11.12% |
| Other Income | 0.40 | 0.91 | 0.77 | 0.88 | 0.81 | 0.67 | 9.29 | 0.21 | 0.31 | 0.39 | 0.44 | 0.37 | 0.30 |
| Interest | 1.84 | 3.16 | 3.29 | 3.47 | 2.88 | 3.56 | 3.85 | 3.01 | 2.77 | 2.53 | 2.19 | 2.03 | 1.91 |
| Depreciation | 4.92 | 4.80 | 4.54 | 3.55 | 3.90 | 3.91 | 4.33 | 4.16 | 4.25 | 4.25 | 4.03 | 4.19 | 4.11 |
| Profit before tax | -2.76 | -5.97 | 9.23 | 4.83 | 3.56 | 0.32 | 8.51 | 1.89 | 8.59 | 11.35 | 9.34 | 11.03 | 8.29 |
| Tax % | 0.00% | -45.23% | 27.63% | 34.99% | 33.71% | 6.25% | 32.20% | 26.46% | 32.36% | 30.57% | 30.73% | 29.74% | 30.64% |
| Net Profit | -2.77 | -3.28 | 6.68 | 3.14 | 2.36 | 0.29 | 5.78 | 1.39 | 5.80 | 7.88 | 6.47 | 7.75 | 5.75 |
| EPS in Rs | -1.11 | -1.32 | 2.68 | 1.26 | 0.95 | 0.12 | 2.32 | 0.56 | 2.33 | 3.16 | 2.59 | 3.11 | 2.31 |
Last Updated: December 27, 2025, 6:03 am
Below is a detailed analysis of the quarterly data for DMCC Speciality Chemicals Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Sales, as of Sep 2025, the value is 126.02 Cr.. The value appears to be declining and may need further review. It has decreased from 127.02 Cr. (Jun 2025) to 126.02 Cr., marking a decrease of 1.00 Cr..
- For Expenses, as of Sep 2025, the value is 112.01 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 110.14 Cr. (Jun 2025) to 112.01 Cr., marking an increase of 1.87 Cr..
- For Operating Profit, as of Sep 2025, the value is 14.01 Cr.. The value appears to be declining and may need further review. It has decreased from 16.88 Cr. (Jun 2025) to 14.01 Cr., marking a decrease of 2.87 Cr..
- For OPM %, as of Sep 2025, the value is 11.12%. The value appears to be declining and may need further review. It has decreased from 13.29% (Jun 2025) to 11.12%, marking a decrease of 2.17%.
- For Other Income, as of Sep 2025, the value is 0.30 Cr.. The value appears to be declining and may need further review. It has decreased from 0.37 Cr. (Jun 2025) to 0.30 Cr., marking a decrease of 0.07 Cr..
- For Interest, as of Sep 2025, the value is 1.91 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 2.03 Cr. (Jun 2025) to 1.91 Cr., marking a decrease of 0.12 Cr..
- For Depreciation, as of Sep 2025, the value is 4.11 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 4.19 Cr. (Jun 2025) to 4.11 Cr., marking a decrease of 0.08 Cr..
- For Profit before tax, as of Sep 2025, the value is 8.29 Cr.. The value appears to be declining and may need further review. It has decreased from 11.03 Cr. (Jun 2025) to 8.29 Cr., marking a decrease of 2.74 Cr..
- For Tax %, as of Sep 2025, the value is 30.64%. The value appears to be increasing, which may not be favorable. It has increased from 29.74% (Jun 2025) to 30.64%, marking an increase of 0.90%.
- For Net Profit, as of Sep 2025, the value is 5.75 Cr.. The value appears to be declining and may need further review. It has decreased from 7.75 Cr. (Jun 2025) to 5.75 Cr., marking a decrease of 2.00 Cr..
- For EPS in Rs, as of Sep 2025, the value is 2.31. The value appears to be declining and may need further review. It has decreased from 3.11 (Jun 2025) to 2.31, marking a decrease of 0.80.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 3:50 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 101 | 120 | 108 | 175 | 178 | 227 | 188 | 200 | 326 | 387 | 328 | 431 | 496 |
| Expenses | 86 | 101 | 91 | 145 | 155 | 174 | 160 | 165 | 286 | 351 | 292 | 374 | 433 |
| Operating Profit | 15 | 20 | 16 | 30 | 23 | 53 | 28 | 36 | 41 | 36 | 36 | 57 | 64 |
| OPM % | 15% | 16% | 15% | 17% | 13% | 24% | 15% | 18% | 12% | 9% | 11% | 13% | 13% |
| Other Income | 6 | -1 | 0 | 1 | 1 | 1 | 6 | 8 | 6 | 3 | 10 | 1 | 2 |
| Interest | 2 | 2 | 1 | 5 | 4 | 3 | 2 | 2 | 5 | 11 | 14 | 10 | 9 |
| Depreciation | 3 | 2 | 2 | 4 | 4 | 5 | 6 | 7 | 8 | 18 | 16 | 17 | 17 |
| Profit before tax | 16 | 14 | 13 | 21 | 16 | 47 | 26 | 34 | 34 | 10 | 17 | 31 | 40 |
| Tax % | 0% | 0% | 9% | 21% | 21% | 2% | -22% | 4% | 37% | 35% | 33% | 31% | |
| Net Profit | 16 | 14 | 12 | 17 | 12 | 46 | 31 | 33 | 21 | 7 | 12 | 22 | 28 |
| EPS in Rs | 7.55 | 6.58 | 5.63 | 7.79 | 4.92 | 18.47 | 12.63 | 13.06 | 8.56 | 2.75 | 4.64 | 8.64 | 11.17 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 10% | 8% | 0% | 15% | 6% | 0% | 22% | 29% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | -12.50% | -14.29% | 41.67% | -29.41% | 283.33% | -32.61% | 6.45% | -36.36% | -66.67% | 71.43% | 83.33% |
| Change in YoY Net Profit Growth (%) | 0.00% | -1.79% | 55.95% | -71.08% | 312.75% | -315.94% | 39.06% | -42.82% | -30.30% | 138.10% | 11.90% |
DMCC Speciality Chemicals Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 14% |
| 5 Years: | 18% |
| 3 Years: | 10% |
| TTM: | 45% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 3% |
| 5 Years: | -7% |
| 3 Years: | 1% |
| TTM: | 184% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 23% |
| 5 Years: | 14% |
| 3 Years: | -8% |
| 1 Year: | 10% |
| Return on Equity | |
|---|---|
| 10 Years: | 16% |
| 5 Years: | 9% |
| 3 Years: | 5% |
| Last Year: | 10% |
Last Updated: September 5, 2025, 3:16 pm
Balance Sheet
Last Updated: December 4, 2025, 2:46 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 21 | 21 | 21 | 25 | 25 | 25 | 25 | 25 | 25 | 25 | 25 | 25 | 25 |
| Reserves | -13 | 1 | 13 | 35 | 48 | 91 | 120 | 148 | 168 | 173 | 184 | 202 | 209 |
| Borrowings | 38 | 35 | 27 | 30 | 25 | 22 | 25 | 35 | 93 | 101 | 88 | 72 | 40 |
| Other Liabilities | 53 | 32 | 34 | 59 | 59 | 51 | 42 | 55 | 97 | 101 | 80 | 81 | 101 |
| Total Liabilities | 99 | 88 | 94 | 149 | 156 | 188 | 212 | 263 | 383 | 400 | 377 | 380 | 374 |
| Fixed Assets | 26 | 24 | 26 | 83 | 87 | 99 | 101 | 108 | 174 | 230 | 238 | 234 | 226 |
| CWIP | 1 | 1 | 5 | 3 | 3 | 1 | 9 | 38 | 63 | 11 | 6 | 0 | 0 |
| Investments | 0 | 0 | 0 | 2 | 4 | 3 | 3 | 1 | 1 | 1 | 1 | 1 | 1 |
| Other Assets | 72 | 63 | 63 | 60 | 62 | 86 | 98 | 116 | 146 | 159 | 132 | 145 | 147 |
| Total Assets | 99 | 88 | 94 | 149 | 156 | 188 | 212 | 263 | 383 | 400 | 377 | 380 | 374 |
Below is a detailed analysis of the balance sheet data for DMCC Speciality Chemicals Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 25.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 25.00 Cr..
- For Reserves, as of Sep 2025, the value is 209.00 Cr.. The value appears strong and on an upward trend. It has increased from 202.00 Cr. (Mar 2025) to 209.00 Cr., marking an increase of 7.00 Cr..
- For Borrowings, as of Sep 2025, the value is 40.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 72.00 Cr. (Mar 2025) to 40.00 Cr., marking a decrease of 32.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 101.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 81.00 Cr. (Mar 2025) to 101.00 Cr., marking an increase of 20.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 374.00 Cr.. The value appears to be improving (decreasing). It has decreased from 380.00 Cr. (Mar 2025) to 374.00 Cr., marking a decrease of 6.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 226.00 Cr.. The value appears to be declining and may need further review. It has decreased from 234.00 Cr. (Mar 2025) to 226.00 Cr., marking a decrease of 8.00 Cr..
- For CWIP, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Investments, as of Sep 2025, the value is 1.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 1.00 Cr..
- For Other Assets, as of Sep 2025, the value is 147.00 Cr.. The value appears strong and on an upward trend. It has increased from 145.00 Cr. (Mar 2025) to 147.00 Cr., marking an increase of 2.00 Cr..
- For Total Assets, as of Sep 2025, the value is 374.00 Cr.. The value appears to be declining and may need further review. It has decreased from 380.00 Cr. (Mar 2025) to 374.00 Cr., marking a decrease of 6.00 Cr..
Notably, the Reserves (209.00 Cr.) exceed the Borrowings (40.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -23.00 | -15.00 | -11.00 | 0.00 | -2.00 | 31.00 | 3.00 | 1.00 | -52.00 | -65.00 | -52.00 | -15.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 61 | 44 | 44 | 45 | 45 | 48 | 48 | 58 | 56 | 49 | 51 | 63 |
| Inventory Days | 52 | 62 | 104 | 60 | 73 | 80 | 113 | 151 | 79 | 78 | 81 | 58 |
| Days Payable | 126 | 76 | 115 | 129 | 114 | 79 | 68 | 116 | 131 | 121 | 119 | 84 |
| Cash Conversion Cycle | -12 | 29 | 33 | -25 | 4 | 49 | 93 | 94 | 3 | 6 | 13 | 37 |
| Working Capital Days | 15 | 1 | -7 | -37 | -6 | 43 | 80 | 32 | -5 | 2 | 5 | 16 |
| ROCE % | 34% | 34% | 24% | 35% | 21% | 43% | 18% | 19% | 16% | 7% | 8% | 14% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 8.63 | 4.65 | 2.78 | 8.56 | 13.06 |
| Diluted EPS (Rs.) | 8.63 | 4.65 | 2.78 | 8.56 | 13.06 |
| Cash EPS (Rs.) | 15.34 | 10.95 | 9.84 | 11.79 | 15.80 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 91.25 | 84.02 | 79.49 | 77.64 | 69.44 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 91.25 | 84.02 | 79.49 | 77.64 | 69.44 |
| Revenue From Operations / Share (Rs.) | 172.93 | 131.50 | 154.26 | 130.83 | 80.25 |
| PBDIT / Share (Rs.) | 23.40 | 18.73 | 15.55 | 18.48 | 17.35 |
| PBIT / Share (Rs.) | 16.70 | 12.43 | 8.49 | 15.25 | 14.61 |
| PBT / Share (Rs.) | 12.48 | 6.92 | 4.25 | 13.69 | 13.65 |
| Net Profit / Share (Rs.) | 8.63 | 4.65 | 2.78 | 8.56 | 13.06 |
| NP After MI And SOA / Share (Rs.) | 8.63 | 4.65 | 2.78 | 8.56 | 13.06 |
| PBDIT Margin (%) | 13.53 | 14.24 | 10.07 | 14.12 | 21.61 |
| PBIT Margin (%) | 9.65 | 9.45 | 5.50 | 11.65 | 18.20 |
| PBT Margin (%) | 7.21 | 5.26 | 2.75 | 10.46 | 17.00 |
| Net Profit Margin (%) | 4.99 | 3.53 | 1.80 | 6.54 | 16.27 |
| NP After MI And SOA Margin (%) | 4.99 | 3.53 | 1.80 | 6.54 | 16.27 |
| Return on Networth / Equity (%) | 9.45 | 5.53 | 3.49 | 11.02 | 18.81 |
| Return on Capital Employeed (%) | 15.38 | 11.47 | 7.88 | 15.10 | 18.68 |
| Return On Assets (%) | 5.66 | 3.07 | 1.72 | 5.56 | 12.35 |
| Long Term Debt / Equity (X) | 0.17 | 0.27 | 0.34 | 0.28 | 0.09 |
| Total Debt / Equity (X) | 0.20 | 0.31 | 0.40 | 0.40 | 0.14 |
| Asset Turnover Ratio (%) | 1.14 | 0.84 | 0.98 | 1.01 | 0.84 |
| Current Ratio (X) | 1.23 | 1.08 | 1.04 | 0.95 | 1.68 |
| Quick Ratio (X) | 0.84 | 0.66 | 0.63 | 0.64 | 1.13 |
| Inventory Turnover Ratio (X) | 9.95 | 4.03 | 5.48 | 5.09 | 2.94 |
| Dividend Payout Ratio (NP) (%) | 11.58 | 0.00 | 35.98 | 5.84 | 11.68 |
| Dividend Payout Ratio (CP) (%) | 6.52 | 0.00 | 10.16 | 4.24 | 9.65 |
| Earning Retention Ratio (%) | 88.42 | 0.00 | 64.02 | 94.16 | 88.32 |
| Cash Earning Retention Ratio (%) | 93.48 | 0.00 | 89.84 | 95.76 | 90.35 |
| Interest Coverage Ratio (X) | 5.56 | 3.40 | 3.67 | 11.84 | 18.03 |
| Interest Coverage Ratio (Post Tax) (X) | 3.05 | 1.84 | 1.66 | 6.48 | 14.57 |
| Enterprise Value (Cr.) | 789.57 | 745.75 | 677.05 | 982.66 | 815.55 |
| EV / Net Operating Revenue (X) | 1.83 | 2.27 | 1.76 | 3.01 | 4.07 |
| EV / EBITDA (X) | 13.53 | 15.96 | 17.46 | 21.32 | 18.85 |
| MarketCap / Net Operating Revenue (X) | 1.74 | 2.09 | 1.56 | 2.78 | 3.96 |
| Retention Ratios (%) | 88.41 | 0.00 | 64.01 | 94.15 | 88.31 |
| Price / BV (X) | 3.29 | 3.27 | 3.02 | 4.69 | 4.58 |
| Price / Net Operating Revenue (X) | 1.74 | 2.09 | 1.56 | 2.78 | 3.96 |
| EarningsYield | 0.02 | 0.01 | 0.01 | 0.02 | 0.04 |
After reviewing the key financial ratios for DMCC Speciality Chemicals Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 8.63. This value is within the healthy range. It has increased from 4.65 (Mar 24) to 8.63, marking an increase of 3.98.
- For Diluted EPS (Rs.), as of Mar 25, the value is 8.63. This value is within the healthy range. It has increased from 4.65 (Mar 24) to 8.63, marking an increase of 3.98.
- For Cash EPS (Rs.), as of Mar 25, the value is 15.34. This value is within the healthy range. It has increased from 10.95 (Mar 24) to 15.34, marking an increase of 4.39.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 91.25. It has increased from 84.02 (Mar 24) to 91.25, marking an increase of 7.23.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 91.25. It has increased from 84.02 (Mar 24) to 91.25, marking an increase of 7.23.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 172.93. It has increased from 131.50 (Mar 24) to 172.93, marking an increase of 41.43.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 23.40. This value is within the healthy range. It has increased from 18.73 (Mar 24) to 23.40, marking an increase of 4.67.
- For PBIT / Share (Rs.), as of Mar 25, the value is 16.70. This value is within the healthy range. It has increased from 12.43 (Mar 24) to 16.70, marking an increase of 4.27.
- For PBT / Share (Rs.), as of Mar 25, the value is 12.48. This value is within the healthy range. It has increased from 6.92 (Mar 24) to 12.48, marking an increase of 5.56.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 8.63. This value is within the healthy range. It has increased from 4.65 (Mar 24) to 8.63, marking an increase of 3.98.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 8.63. This value is within the healthy range. It has increased from 4.65 (Mar 24) to 8.63, marking an increase of 3.98.
- For PBDIT Margin (%), as of Mar 25, the value is 13.53. This value is within the healthy range. It has decreased from 14.24 (Mar 24) to 13.53, marking a decrease of 0.71.
- For PBIT Margin (%), as of Mar 25, the value is 9.65. This value is below the healthy minimum of 10. It has increased from 9.45 (Mar 24) to 9.65, marking an increase of 0.20.
- For PBT Margin (%), as of Mar 25, the value is 7.21. This value is below the healthy minimum of 10. It has increased from 5.26 (Mar 24) to 7.21, marking an increase of 1.95.
- For Net Profit Margin (%), as of Mar 25, the value is 4.99. This value is below the healthy minimum of 5. It has increased from 3.53 (Mar 24) to 4.99, marking an increase of 1.46.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 4.99. This value is below the healthy minimum of 8. It has increased from 3.53 (Mar 24) to 4.99, marking an increase of 1.46.
- For Return on Networth / Equity (%), as of Mar 25, the value is 9.45. This value is below the healthy minimum of 15. It has increased from 5.53 (Mar 24) to 9.45, marking an increase of 3.92.
- For Return on Capital Employeed (%), as of Mar 25, the value is 15.38. This value is within the healthy range. It has increased from 11.47 (Mar 24) to 15.38, marking an increase of 3.91.
- For Return On Assets (%), as of Mar 25, the value is 5.66. This value is within the healthy range. It has increased from 3.07 (Mar 24) to 5.66, marking an increase of 2.59.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.17. This value is below the healthy minimum of 0.2. It has decreased from 0.27 (Mar 24) to 0.17, marking a decrease of 0.10.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.20. This value is within the healthy range. It has decreased from 0.31 (Mar 24) to 0.20, marking a decrease of 0.11.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 1.14. It has increased from 0.84 (Mar 24) to 1.14, marking an increase of 0.30.
- For Current Ratio (X), as of Mar 25, the value is 1.23. This value is below the healthy minimum of 1.5. It has increased from 1.08 (Mar 24) to 1.23, marking an increase of 0.15.
- For Quick Ratio (X), as of Mar 25, the value is 0.84. This value is below the healthy minimum of 1. It has increased from 0.66 (Mar 24) to 0.84, marking an increase of 0.18.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 9.95. This value exceeds the healthy maximum of 8. It has increased from 4.03 (Mar 24) to 9.95, marking an increase of 5.92.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 11.58. This value is below the healthy minimum of 20. It has increased from 0.00 (Mar 24) to 11.58, marking an increase of 11.58.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 6.52. This value is below the healthy minimum of 20. It has increased from 0.00 (Mar 24) to 6.52, marking an increase of 6.52.
- For Earning Retention Ratio (%), as of Mar 25, the value is 88.42. This value exceeds the healthy maximum of 70. It has increased from 0.00 (Mar 24) to 88.42, marking an increase of 88.42.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 93.48. This value exceeds the healthy maximum of 70. It has increased from 0.00 (Mar 24) to 93.48, marking an increase of 93.48.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 5.56. This value is within the healthy range. It has increased from 3.40 (Mar 24) to 5.56, marking an increase of 2.16.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 3.05. This value is within the healthy range. It has increased from 1.84 (Mar 24) to 3.05, marking an increase of 1.21.
- For Enterprise Value (Cr.), as of Mar 25, the value is 789.57. It has increased from 745.75 (Mar 24) to 789.57, marking an increase of 43.82.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 1.83. This value is within the healthy range. It has decreased from 2.27 (Mar 24) to 1.83, marking a decrease of 0.44.
- For EV / EBITDA (X), as of Mar 25, the value is 13.53. This value is within the healthy range. It has decreased from 15.96 (Mar 24) to 13.53, marking a decrease of 2.43.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 1.74. This value is within the healthy range. It has decreased from 2.09 (Mar 24) to 1.74, marking a decrease of 0.35.
- For Retention Ratios (%), as of Mar 25, the value is 88.41. This value exceeds the healthy maximum of 70. It has increased from 0.00 (Mar 24) to 88.41, marking an increase of 88.41.
- For Price / BV (X), as of Mar 25, the value is 3.29. This value exceeds the healthy maximum of 3. It has increased from 3.27 (Mar 24) to 3.29, marking an increase of 0.02.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 1.74. This value is within the healthy range. It has decreased from 2.09 (Mar 24) to 1.74, marking a decrease of 0.35.
- For EarningsYield, as of Mar 25, the value is 0.02. This value is below the healthy minimum of 5. It has increased from 0.01 (Mar 24) to 0.02, marking an increase of 0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in DMCC Speciality Chemicals Ltd:
- Net Profit Margin: 4.99%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 15.38% (Industry Average ROCE: 12.99%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 9.45% (Industry Average ROE: 25.41%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 3.05
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 0.84
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 22.1 (Industry average Stock P/E: 66.29)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.2
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 4.99%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Chemicals - Speciality - Others | Prospect Chambers, 317/321, Dr. Dadabhoy Naoroji Road, Mumbai Maharashtra 400001 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Laxmikumar Narottam Goculdas | Chairman |
| Ms. Mitika Laxmikumar Goculdas | Vice Chairperson |
| Mr. Bimal Lalitsingh Goculdas | Managing Director & CEO |
| Mr. Kuldeep Kumar Tiwari | Executive Director - Operations |
| Mr. Mukul Manoharlal Taly | Ind. Non-Executive Director |
| Mr. Sanjeev Vishwanath Joshi | Ind. Non-Executive Director |
| Dr.(Mrs.) Janaki Ashwin Patwardhan | Ind. Non-Executive Director |
| Mr. Haren Devidas Parekh | Ind. Non-Executive Director |
FAQ
What is the intrinsic value of DMCC Speciality Chemicals Ltd?
DMCC Speciality Chemicals Ltd's intrinsic value (as of 07 January 2026) is ₹167.01 which is 32.38% lower the current market price of ₹247.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's ₹615 Cr. market cap, FY2025-2026 high/low of ₹393/230, reserves of ₹209 Cr, and liabilities of ₹374 Cr.
What is the Market Cap of DMCC Speciality Chemicals Ltd?
The Market Cap of DMCC Speciality Chemicals Ltd is 615 Cr..
What is the current Stock Price of DMCC Speciality Chemicals Ltd as on 07 January 2026?
The current stock price of DMCC Speciality Chemicals Ltd as on 07 January 2026 is ₹247.
What is the High / Low of DMCC Speciality Chemicals Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of DMCC Speciality Chemicals Ltd stocks is ₹393/230.
What is the Stock P/E of DMCC Speciality Chemicals Ltd?
The Stock P/E of DMCC Speciality Chemicals Ltd is 22.1.
What is the Book Value of DMCC Speciality Chemicals Ltd?
The Book Value of DMCC Speciality Chemicals Ltd is 93.8.
What is the Dividend Yield of DMCC Speciality Chemicals Ltd?
The Dividend Yield of DMCC Speciality Chemicals Ltd is 1.01 %.
What is the ROCE of DMCC Speciality Chemicals Ltd?
The ROCE of DMCC Speciality Chemicals Ltd is 14.1 %.
What is the ROE of DMCC Speciality Chemicals Ltd?
The ROE of DMCC Speciality Chemicals Ltd is 9.97 %.
What is the Face Value of DMCC Speciality Chemicals Ltd?
The Face Value of DMCC Speciality Chemicals Ltd is 10.0.